Skip to main content

Posts

Showing posts from September, 2010

Almost 16,000 COVID-19 patients get hydroxychloroquine and here's what happened

In a new study from Brigham and Women’s hospital, nearly 16,000 patient outcomes were analyzed that were diagnosed with COVID-19 and received the drug hydroxychloroquine.
Instead of improving, patients were four times more likely to experience dangerous heart irregularity, compared to those not teated with the antimalarial drug.
Patients in the study that were given hydroxychloroquine were also more likely to die.
The study is recently published in the medical journal The Lancet  and is the most recent to address a hot topic about whether the medication, which is also prescribed to treat autoimmune disorders, should be  used to treat COVID-19.
Mandeep R. Mehra, a corresponding study author and executive director of the Brigham’s Center for Advanced Heart  Disease said the drug, or any regimen including a chloroquine,  did not help “no matter which way you examine the data.”
Patients from six continents included 
The researchers looked at data from 671 hospitals that included six continents …

Survey Finds Marijuana not a Gateway for Teen Drug use

Researchers find that that pot smoking among teens is not a gateway that leads to harder drug use. Instead, policy makers should focus on other factors found in a survey that influence teen drug use, that include race, ethnicity, stress and unemployment

The biggest predictor of illicit drug use among teens was found to be race and ethnicity, according to research from University of New Hampshire. Pot smoking and use of illicit drugs among teens fades with lower stress levels, found from a survey of 1,286 young adults.

Gateway to Harder Drugs from Marijuana Short-Lived

By age 21, the risk of marijuana's gateway effect to harder drugs subsides. The researchers say, “While marijuana use may serve as a gateway to other illicit drug use in adolescence, our results indicate that the effect may be short-lived, subsiding by age 21.

Interestingly, age emerges as a protective status above and beyond the other life statuses and conditions considered here. We find that respondents ‘age out’ o…